Gilbert H. Kliman - 02 Aug 2022 Form 4 Insider Report for Doximity, Inc. (DOCS)

Reporting relationship: The Reporting Person ceased to be a Director of the Issuer effective 8/2/2022
Issuer ticker: DOCS
Reported as of: 02 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2022, 17:32:06 UTC
Prior SEC filing: 29 Jul 2022
Next SEC filing: 08 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Karen A. Wilson, Attorney-in Fact for Gilbert H. Kliman

Key filing fact

Gilbert H. Kliman filed Form 4 for Doximity, Inc. (DOCS) on 05 Aug 2022.

Key facts

This page summarizes Gilbert H. Kliman's Form 4 filing for Doximity, Inc. (DOCS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Aug 2022, 17:32.

Change

Previous filing in this sequence was filed on 29 Jul 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DOCS transaction

Class A Common Stock

Disposed to Issuer

Transaction value
Shares: -4,714
Change %: -1%
Price
Shares after: 449,960
Date: 02 Aug 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Gilbert H. Kliman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Termination of restricted stock units, originally granted on July 27, 2022 pursuant to the Issuer's non-employee director compensation policy, due to Reporting Person's resignation from the Board of Directors on 8/2/2022.

SEC remarks

The Reporting Person ceased to be a Director of the Issuer effective 8/2/2022